(Press-News.org) A laboratory study led by UNC medical oncologist Stergios Moschos, MD, demonstrates how a new targeted drug, Elesclomol, blocks oxidative phosphorylation, which appears to play essential role in melanoma that has not been well-understood. Elesclomol (Synta Pharmaceuticals, Lexington, MA) was previously shown to have clinical benefit only in patients with normal serum lactate dehydrogenase (LDH), a laboratory test routinely used to assess activity of disease.
For more than 60 years, scientists have known that cancer cells undergo glycolysis, or metabolize glucose, at a much higher rate than normal cells. The observation, called the Warburg effect, demonstrated that the normal energy producing processes in the cell are disrupted in cancer cells, preventing them from using metabolic pathways in the cell's mitochondria (often called the cell's "power plants").
Recently, however, increasing evidence suggests that, in addition to glycolysis, other metabolic pathways may also play a role in cancer, with important therapeutic implications. A promising strategy for targeting cancer cells, while sparing normal cells, is to target these altered metabolic processes with drug therapies. Elesclomol has been shown to trigger cell death in metastatic melanoma cells, primarily by suppressing oxidative phosphorylation – the process that cells use to transform nutrients into energy.
Moschos and his team demonstrated in the lab that metastatic melanoma cells exhibit a higher rate of glycolysis compared to their normal counterpart cells, termed melanocytes, which would be expected due to the Warburg effect.
"But we also found, surprisingly, that these cells have higher rates of oxidative phosphorylation – they are producing energy through more than one pathway, which explains a lot about how the drug works," says Dr. Moschos.
He notes that this drug has an interesting history. In a 600-patient phase III clinical trial conducted almost 4 years ago, Elesclomol had clinical benefit in the subgroup of patients with normal serum LDH. However, the FDA discontinued the trial, because the Elesclomol in combination with another chemotherapeutic drug may have negative effects in patients with high serum LDH, which is associated with poorer patient outcomes in metastatic melanoma. At the time, very little was known about Elesclomol's mechanism of action – blocking oxidative phosphorylation.
"Our inability to show how Elesclomol worked through measurement of biomarkers was the major driver to conduct this laboratory study," said Moschos, whose team took the clinical trial results back to the lab to try to figure out why the drug worked.
"Our results suggest that targeting oxidative phosphorylation in melanoma is a promising strategy for early metastatic disease, before melanoma cells switch their primary metabolic source to glycolysis, as Otto Warburg showed 60 years ago" said Dr. Moschos.
"Second, we were able to demonstrate a mechanism of resistance to Elesclomol, where long-term exposure to the drug leads to the selection of melanoma cells with high levels of glycolysis. This suggests that a two-pronged strategy aimed at blocking both metabolic pathways may be called for."
The results of the study were published today in the journal Public Library of Science One.
###
Dr. Moschos conducted the research when he was a faculty member at the University of Pittsburgh Melanoma and Skin Cancer Program in collaboration with Dr. Bennett Van Houten, Richard M. Cyert Chair in Molecular Oncology, University of Pittsburgh. He joined UNC's division of hematology/oncology and UNC Lineberger Comprehensive Cancer Center in January. The research appears today in Public Library of Science ONE.
Other members of the research team include scientists from the University of Pittsburgh, the Women's Health Integrated Research Center at Inova Health System in Annandale, VA, Carnegie Mellon University and the University of Heidelberg.
The project was funded by a Career Development Award of a SPORE in Skin Cancer at the University of Pittsburgh (National Cancer Institute grant P50CA121973 ) and a Pennsylvania Department of Health PA CURE award. Synta Pharmaceuticals Corporation provided the Elesclomol drug used in the laboratory research.
END
LOS ALAMOS, N.M., August 17, 2012 — Members of the Mars Science Laboratory Curiosity rover ChemCam team have received the first photos from the instrument's remote micro imager. The successful capture of ChemCam's first 10 photos sets the stage for the first test bursts of the instrument's rock-zapping laser in the near future.
"The successful delivery of these photos means we can begin efforts in earnest for the first images of Mars rocks by the ChemCam instrument and the first use of the instrument's laser," said Los Alamos National Laboratory planetary scientist Roger ...
A mysterious region deep in the human brain could be where we sort through the onslaught of stimuli from the outside world and focus on the information most important to our behavior and survival, Princeton University researchers have found.
The researchers report in the journal Science that an area of our brain called the pulvinar regulates communication between clusters of brain cells as our brain focuses on the people and objects that need our attention. Like a switchboard operator, the pulvinar makes sure that separate areas of the visual cortex — which processes ...
TORONTO, Ontario (August 17, 2012) –An 'all-natural' method for studying pancreatic islets, the small tissues responsible for insulin production and regulation in the body, has recently been developed by researchers at the University of Toronto's Institute of Biomaterials and Biomedical Engineering (IBBME) to try to track metabolic changes in living tissues in 'real time' and without additional chemicals or drugs.
It's an organically-minded approach that could lead to big changes in our understanding of diabetes and other diseases.
Assistant Professor Jonathon V. ...
DETROIT — Correctional facility employees who trust supervisors and management are less likely to experience job burnout, a Wayne State University researcher has found.
"Trust builds commitment and involvement in the job," said Eric Lambert, Ph.D., professor and chair of criminal justice in the College of Liberal Arts and Sciences, "but lack of trust leads to burnout and stresses people out."
A correctional facility employee himself before becoming an academic, Lambert developed his study of staff members at a private Midwestern juvenile detention facility after learning ...
Satellite imagery on August 17 is showing signs of re-organization in the remnants of Tropical Depression 7 (TD7). TD7 has moved into the warm waters of the Bay of Campeche where it is regaining strength and appears much more organized.
NASA's GOES Project created a visible image of the remnants of Tropical Depression 7 from August 17 at 9:45 a.m. EDT (1345 UTC) from NOAA's GOES-13 satellite. The image showed several areas of stronger thunderstorms. The stronger thunderstorms appear brighter white in the imagery and are located around the center and to the northeast of ...
DENVER — New research shows that people who have bariatric surgery to treat obesity report an overall improvement in quality of life issues after surgery, from their relationships to their medical conditions. Arizona State University researchers will present their findings at the 107th Annual Meeting of the American Sociological Association.
Obesity is an epidemic in the United States with more than one-third of adults over age 20 classified as obese. Bariatric surgery is an increasingly common procedure that individuals are turning to that typically results in dramatic ...
DENVER — New research examining relationships and the use of alcohol finds that while a long-term marriage appears to curb men's drinking, it's associated with a slightly higher level of alcohol use among women. The study, led by the University of Cincinnati (UC), will be presented at the 107th Annual Meeting of the American Sociological Association.
Based on survey data and interviews, the authors revealed that married men reported consuming the lowest number of drinks, compared with single, divorced, and widowed men. That's in part because of their wives' lower levels ...
DENVER — Women playing full-contact tackle football face challenges beyond the playing field—yet there's little research about this niche in athletics. Jennifer Carter, a University of Cincinnati doctoral student in the UC Department of Sociology, will present her research on body maintenance in women's professional football at the 107th Annual Meeting of the American Sociological Association.
Carter first began her research observing a team in the Women's Football Alliance (WFA), but she then became a defensive back, and learned firsthand how women condition themselves ...
The way legislators, experts and other opinion leaders discuss the role of parents and schools in reducing educational inequalities has changed dramatically since the Elementary and Secondary Education Act first passed in 1965. Put simply, parents were viewed as part of the problem then, with schools seen as the solution. In recent years, with No Child Left Behind and more school choice options, these roles have flipped.
"There has been a continued focus on reducing educational inequalities; however, there are stark contrasts in the way policymakers and experts talked ...
Integrate is almost here and so is Homony! A relative newcomer to the commercial audio world, Homony will be displaying its products at Integrate 2012 to be held on 21-23 Aug 2012 at Sydney Convention & Exhibition Centre, Melbourne. Look out for Homony's wide range of products on display at booth A9. Don't miss this opportunity to check out our low cost solutions for small, medium and large sized applications. On display, will be our enhanced Audio Matrix System that comes with remote control panels and sleek paging microphones. Check out our all-in-one BGM and public ...
